Page last updated: 2024-11-10

pyridoxal thiosemicarbazone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pyridoxal thiosemicarbazone: copper complexes of pyridoxal thiosemicarbazone exert action of inducing agents & are able to enhance dimethylsulfoxide induced hemopoietic differention [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135455548
MeSH IDM0202502

Synonyms (3)

Synonym
pyridoxal thiosemicarbazone
nsc 47407
hydrazinecarbothioamide, 2-((3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinyl)methylene)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]